Log in to save to my catalogue

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities...

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1285092536

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome

About this item

Full title

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome

Publisher

London: Nature Publishing Group UK

Journal title

The pharmacogenomics journal, 2013-02, Vol.13 (1), p.70-79

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Brain imaging studies contribute to the neurobiological understanding of Autism Spectrum Conditions (ASC). Herein, we tested the prediction that distributed neurodevelopmental abnormalities in brain development impact on the homogeneity of brain tissue measured using texture analysis (TA; a morphological method for surface pattern characterization)...

Alternative Titles

Full title

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1285092536

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1285092536

Other Identifiers

ISSN

1470-269X

E-ISSN

1473-1150

DOI

10.1038/tpj.2012.3

How to access this item